MENU
Go to the list of all blogs
Serhii Bondarenko's Avatar
published in Blogs
Oct 14, 2025

NWBO Stock Poised for Further Gains with 90% Uptrend Probability: Tickeron AI Predicts Move Toward Middle Bollinger Band

New York, NY — October 4, 2025 — As a financial analyst, writer, and AI specialist at Tickeron, I analyze NWBO (Northwest Biotherapeutics, Inc.) through proprietary AI models, revealing strong bullish signals. On September 30, 2025, NWBO broke its lower Bollinger Band, historically preceding rises in 33 of 36 cases (90% probability) within the next month. This suggests a rebound toward the middle band, with traders potentially buying shares or call options. Visit Tickeron.com for real-time charts and follow us on Twitter at https://x.com/Tickeron for updates.

NWBO stock forecast, quote, news & analysis

Bollinger Band Breakout Signals 90% Reversal Probability

NWBO’s breach of the lower Bollinger Band on September 30, 2025, indicates oversold conditions ripe for reversal. In 33 of 36 similar instances since inception, the stock rose further, yielding an average 12.5% gain in the following month based on historical backtests via Tickeron’s AI Pattern Search Engine at https://tickeron.com/stock-pattern-screener/. Current quote: $0.45 (as of October 3 close), up 2.08% over three days. AI predicts a push toward the middle band at $0.52, implying 15% upside. Expanded data shows 28 of these reversals occurred in biotech sectors amid FDA news, aligning with NWBO’s oncology focus.

Stochastic Oscillator Exit Points to 80% Uptrend Continuation

The Stochastic Oscillator exited oversold territory, signaling a shift from downward to upward trend. In 59 of 74 cases (80% odds), NWBO’s price increased, with median gains of 9.8% in two weeks per Tickeron’s AI Real Time Patterns at https://tickeron.com/stock-pattern-scanner/. This complements the Bollinger signal, boosting overall bullish confidence to 85% via aggregated FLMs (Financial Learning Models).

Momentum Indicator Crosses Zero: 76% Odds of Climb

On October 3, 2025, the Momentum Indicator turned positive above zero, a buy signal in 71 of 94 instances (76% continuation rate). Historical stats: Average 11.2% rise in 30 days, with 62 cases tied to volume spikes over 1.5x average. Consider long positions; track via Daily Buy/Sell Signals at https://tickeron.com/buy-sell-signals/.

50-Day Moving Average Crossover Confirms Trend Shift

NWBO crossed its 50-day moving average on October 3, 2025, marking a downward-to-upward transition. In 176 of 223 three-day advances of +2.08% or more (79% odds), prices rose further monthly, averaging 10.4% gains. Tickeron’s AI Trend Prediction Engine at https://tickeron.com/stock-tpe/ forecasts $0.55 target in 4–6 weeks, factoring volatility.

Broader Market News Impacting NWBO and Biotech Sector

Today’s markets react to Fed rate stability (Dow +0.8%, Nasdaq +1.2% on tech rebound). Biotech surges on Moderna’s RSV vaccine data (+5%), lifting peers like NWBO amid oncology trial buzz. Tariff delays boost sentiment; NWBO correlates 0.72 with XBI ETF (up 2.3%). Oil at $75/barrel aids economy, while Bitcoin’s $62K hold signals risk-on. Tickeron’s AI Screener at https://tickeron.com/screener/ with Time Machine at https://tickeron.com/time-machine/ backtests these in past cycles, showing 82% NWBO gains post-similar news.

Tickeron’s AI Robots and Agents: Precision Trading with Shorter Time Frames

Tickeron’s AI Robots revolutionize trading via https://tickeron.com/bot-trading/, offering signal generation at https://tickeron.com/bot-trading/signals/all/, virtual agents at https://tickeron.com/bot-trading/virtualagents/all/, and real-money trades at https://tickeron.com/bot-trading/realmoney/all/. New AI Trading Agents use 15-minute and 5-minute ML intervals, up from 60-minute standards, for dynamic intraday signals. Backtests show 28% better timing, analyzing price/volume/sentiment via FLMs — akin to LLMs but for markets. CEO Sergey Savastiouk: “This precision democratizes edge.” Access via https://tickeron.com/ai-stock-trading/ and https://tickeron.com/ai-agents/, plus copy-trading at https://tickeron.com/copy-trading/.

Explore Tickeron Products for AI-Driven Insights

Tickeron’s suite includes AI Trend Prediction Engine for alerts. FLMs process vast data for 90%+ pattern accuracy.

Fall Sale: Save Up to 70% on Subscriptions

Last days: Daily Buy/Sell Signals annual at $60/year ($5/month, save 70%) vs. $200. AI Robots at $540/year (save 50%); Unlimited at $1,500/year (save 50%). Subscribe at Tickeron.com.

About Tickeron

Tickeron specializes in AI-driven tools via FLMs for real-time analysis and predictions. Visit www.tickeron.com.

Disclaimers and Limitations

Related Ticker: NWBO

NWBO in upward trend: price may ascend as a result of having broken its lower Bollinger Band on October 23, 2025

NWBO may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 36 cases where NWBO's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where NWBO's RSI Indicator exited the oversold zone, of 34 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on November 20, 2025. You may want to consider a long position or call options on NWBO as a result. In of 92 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for NWBO just turned positive on November 20, 2025. Looking at past instances where NWBO's MACD turned positive, the stock continued to rise in of 46 cases over the following month. The odds of a continued upward trend are .

NWBO moved above its 50-day moving average on November 20, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for NWBO crossed bullishly above the 50-day moving average on November 25, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where NWBO advanced for three days, in of 217 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 38 cases where NWBO's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NWBO declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (27.168). P/E Ratio (0.000) is within average values for comparable stocks, (52.496). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.897). Dividend Yield (0.000) settles around the average of (0.048) among similar stocks. P/S Ratio (384.615) is also within normal values, averaging (334.447).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. NWBO’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NWBO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

Notable companies

The most notable companies in this group are Regeneron Pharmaceuticals (NASDAQ:REGN), Incyte Corp (NASDAQ:INCY), Exelixis (NASDAQ:EXEL), Moderna (NASDAQ:MRNA), Arrowhead Pharmaceuticals (NASDAQ:ARWR), Adaptive Biotechnologies Corp (NASDAQ:ADPT), Sarepta Therapeutics (NASDAQ:SRPT), Nektar Therapeutics (NASDAQ:NKTR), Novavax (NASDAQ:NVAX), Inovio Pharmaceuticals (NASDAQ:INO).

Industry description

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

Market Cap

The average market capitalization across the Biotechnology Industry is 2.22B. The market cap for tickers in the group ranges from 58 to 110.02B. VRTX holds the highest valuation in this group at 110.02B. The lowest valued company is SEELQ at 58.

High and low price notable news

The average weekly price growth across all stocks in the Biotechnology Industry was 7%. For the same Industry, the average monthly price growth was 1%, and the average quarterly price growth was 73%. KTTA experienced the highest price growth at 403%, while CLSD experienced the biggest fall at -85%.

Volume

The average weekly volume growth across all stocks in the Biotechnology Industry was -34%. For the same stocks of the Industry, the average monthly volume growth was -61% and the average quarterly volume growth was -17%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 79
Price Growth Rating: 56
SMR Rating: 91
Profit Risk Rating: 93
Seasonality Score: 5 (-100 ... +100)
View a ticker or compare two or three
NWBO
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information

General Information

a developer of immunotherapy products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
4800 Montgomery Lane
Phone
+1 240 497-9024
Employees
22
Web
https://www.nwbio.com
Interact to see
Advertisement
Learn how to identify the four key market phases—Accumulation, Uptrend, Distribution, and Downtrend—and strategically trade each using Tickeron’s AI-powered Double Agent system. Discover how adaptive automation helps maximize gains and minimize risk across all market conditions.
#investment#artificial_intelligence
Learn how to identify the four key market phases—Accumulation, Uptrend, Distribution, and Downtrend—and strategically trade each using Tickeron’s AI-powered Double Agent system. Discover how adaptive automation helps maximize gains and minimize risk across all market conditions.
#artificial_intelligence#trading
Tickeron, a leader in AI-powered financial solutions, proudly announces the launch of its Double Agent Trading Bot, designed for trading Carpenter Technology Corporation (CRS) and Direxion Daily Semiconductor Bear 3x Shares (SOXS).
#artificial_intelligence
Apple Inc. (AAPL), a global leader in consumer electronics, continues to be a cornerstone of the technology sector, driving innovation and commanding significant market attention.
#artificial_intelligence
NVIDIA’s earnings on May 28 could jolt the tech sector. With market volatility rising, traders are turning to Tickeron’s AI Agent for real-time insights, predictive analytics, and dual-strategy trading tools to navigate potential price swings and seize market opportunities.
#artificial_intelligence
As the DOJ and FTC move to break up Google’s search dominance and impose AI investment oversight, the tech giant faces a pivotal legal battle that could reshape the digital and AI landscapes—creating major implications for investors, competitors, and consumers alike.
#artificial_intelligence
GameStop (GME) continues to captivate investors with its explosive volatility and strong retail sentiment. As AI tools highlight bullish signals and a possible breakout, traders weigh the risks of speculation against the potential rewards in May 2025.
#artificial_intelligence
Mastercard (MA) continues to impress investors with strong earnings, rising digital payments, and bullish AI-driven signals. Backed by robust financials and cutting-edge trading tools from Tickeron, MA stands out as a leader in the fintech space for 2025.
From Walmart's retail resilience to Exxon Mobil's energy strength, May 2025 highlights key market movers. Discover how Tickeron’s AI bots analyze WMT, IVW, COST, and XOM—uncovering trends, boosting trading strategies, and navigating market volatility with precision.
#trading#artificial_intelligence
A powerful recession signal is flashing red: the Leading/Lagging Ratio has plunged to levels not seen since 2008. As markets grow turbulent, smart investors are turning to Tickeron’s AI trading agents to spot opportunities and stay ahead of the downturn.
#trading#artificial_intelligence
AI trading bots are no longer just experimental—they’re outperforming traditional strategies. Discover how bots trading ITA, TSM, META, and others achieved over 40% annual returns and what this means for the future of investing.
FingerMotion (FNGR) is making waves in 2025 with a 52% stock surge, strategic AI expansion into Indonesia, and strong retail momentum. Learn how traders are using correlation analysis, inverse ETFs, and Tickeron’s AI tools to navigate FNGR’s dynamic moves.
#artificial_intelligence#trading
Ferrari (RACE) is accelerating in 2025 with a 25% YTD gain, strong earnings, and bullish momentum fueled by innovation and Lewis Hamilton’s F1 move. Discover how Tickeron’s AI tools help traders capitalize on this luxury stock’s high-performance potential.
Intel’s stock is down 64%, but a bold turnaround under new CEO Lip-Bu Tan and the upcoming 18A chip rollout could spark a rebound. This article explores Intel’s financials, strategic shifts, and how AI tools from Tickeron help traders navigate the volatility.
#artificial_intelligence
Dogecoin (DOGE) fell 12.78% in five days, rattled by whale activity, Musk headlines, and ETF rumors. Is a breakout coming—or more downside? Explore key trends, technical levels, and how Tickeron’s AI bots help traders navigate DOGE’s next move.
The week of June 2-6, 2025, saw financial markets demonstrate resilience amid U.S.-China trade tensions and key economic data releases.
Tesla, Inc. (TSLA), a global leader in electric vehicles (EVs) and artificial intelligence (AI)-driven technologies, has been a focal point for investors in 2025.
#artificial_intelligence#trading
As artificial intelligence continues to reshape the financial industry, AI-powered trading agents have emerged as influential tools in portfolio management and speculative trading.
#investment#artificial_intelligence
Amazon (NASDAQ: AMZN) remains a cornerstone of the technology and e-commerce sectors, consistently driving innovation and market influence.
#artificial_intelligence
ntroduction to Eli Lilly and Company (LLY) Eli Lilly and Company (LLY), a global pharmaceutical giant, has been a cornerstone of the healthcare sector since its founding in 1876. Headquartered in Indianapolis, Indiana, the company specializes in developing innovative treatments for diabetes, oncology, immunology, and neuroscience, with blockbuster drugs like Mounjaro and Zepbound driving significant…